Therefore, we suggest that agents that can modulate cellular stress, such as an activator of AMPK or inhibitors of lipid synthesis, could potentially enhance the killing of Rb mutant cancer cells by inhibiting TSC2. This evidence concerns the gene RB1 and cancer.